V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008352 | 280005547 | 1.53 | 55.7 | Curative (C) | 2017-12-05 | 2017-12-05 | STS Rhabdomyosarcoma RMS 2005 IVADo | null | null | 280027222 | RMS 2005 TRIAL |
| 280008353 | 280005549 | 1.69 | 78.9 | Curative (C) | 2017-06-27 | 2017-07-22 | Cetuximab + Radiotherapy Maint | N | N | 280027242 | CETUXIMAB + RT |
| 280008354 | 280005550 | 1.8 | 84 | Curative (C) | null | 2015-05-15 | Cetuximab + Radiotherapy Load | N | N | 280027256 | CETUXIMAB + RT |
| 280008355 | 280005551 | 1.62 | null | Palliative (P) | 2013-10-31 | 2013-10-31 | Doxorubicin 75mg/m2 | 01 | N | 280027268 | DOXORUBICIN |
| 280008356 | 280008915 | 0 | 58 | null | 2014-04-26 | 2014-04-27 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280027268 | RMS 2005 TRIAL |
| 280008357 | 280005552 | 1.75 | 16.1 | Palliative (P) | 2014-10-29 | 2014-11-05 | Cetuximab + Radiotherapy Maint | Y | null | 280027276 | CETUXIMAB + RT |
| 280008358 | 280005553 | 1.84 | 11.3 | Adjuvant (A) | 2014-07-07 | 2014-07-15 | DOXORUBICIN | N | N | 280027277 | DOXORUBICIN |
| 280008359 | 280005554 | 1.82 | null | Palliative (P) | 2016-07-24 | 2016-08-14 | Ifosfamide | Y | null | 280027281 | IFOSFAMIDE |
| 280008360 | 280005555 | 1.54 | 78 | null | 2016-07-23 | 2016-09-06 | PACLITAXEL | N | N | 280027285 | PACLITAXEL |
| 280008361 | 280005556 | 1.52 | 48.8 | Curative (C) | 2017-03-18 | 2017-07-22 | Cetuximab + Radiotherapy Maint | Y | N | 280027291 | CETUXIMAB + RT |
| 280008362 | 280005557 | 1.45 | 100 | Palliative (P) | 2015-02-02 | 2015-02-02 | Doxorubicin 75mg/m2 | Y | N | 280027294 | DOXORUBICIN |
| 280008363 | 280005557 | 1.06 | 50.6 | Curative (C) | 2016-12-21 | 2017-06-30 | STS Rhabdo RMS 2005 Vin Cyclo | N | Y | 280027294 | RMS 2005 TRIAL |
| 280008364 | 280005557 | 1.77 | null | Curative (C) | 2017-02-07 | 2017-03-21 | Cetuximab + Radiotherapy Maint | N | null | 280027294 | CETUXIMAB + RT |
| 280008365 | 280005558 | 1.8 | 49 | Neo-adjuvant (N) | 2018-04-13 | 2018-05-12 | DOXORUBICIN | 02 | N | 280027305 | DOXORUBICIN |
| 280008366 | 280005558 | 1.65 | null | Palliative (P) | null | 2013-08-19 | Cetuximab + Radiotherapy Maint | N | N | 280027305 | CETUXIMAB + RT |
| 280008367 | 280005559 | 0 | 72.7 | null | 2015-08-25 | 2015-08-25 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280027318 | IVA |
| 280008368 | 280005560 | 1.7 | 116 | Palliative (P) | 2017-02-16 | 2018-05-10 | DOXORUBICIN | 02 | N | 280027320 | DOXORUBICIN |
| 280008369 | 280005560 | 0 | 90 | Palliative (P) | 2013-07-01 | 2013-12-15 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 280027320 | RMS 2005 TRIAL |
| 280008370 | 280008920 | 1.76 | 90 | Palliative (P) | 2016-08-09 | 2016-08-09 | DOXORUBICIN | N | N | 280027325 | DOXORUBICIN |
| 280008371 | 280008920 | 1.73 | 11.5 | null | 2016-03-15 | 2016-03-17 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 280027325 | PACLITAXEL |
| 280008372 | 280005562 | 1.54 | 63 | Palliative (P) | 2017-06-30 | 2017-08-14 | IVA | 02 | N | 280027329 | IVA |
| 280008373 | 280005562 | 1.82 | 90 | Not known (9) | 2014-02-08 | 2014-02-15 | PACLITAXEL | 2 | N | 280027329 | PACLITAXEL |
| 280008374 | 280005563 | 1.63 | 41.6 | Curative (C) | 2015-09-21 | 2015-11-19 | Cisplatin | 02 | N | 280027343 | CISPLATIN |
| 280008375 | 280005564 | 0 | 64.8 | Curative (C) | 2016-04-30 | 2016-06-11 | STS Rhabdomyosarcoma RMS 2005 IVADo | null | null | 280027346 | RMS 2005 TRIAL |
| 280008376 | 280008922 | 1.81 | 85.2 | Palliative (P) | 2013-03-13 | 2015-05-26 | DOXORUBICIN | N | N | 280027349 | DOXORUBICIN |
| 280008377 | 280008922 | 1.61 | 52.5 | Palliative (P) | 2017-12-30 | 2018-01-21 | Doxorubicin 75mg/m2 | 02 | N | 280027349 | DOXORUBICIN |
| 280008378 | 280010544 | 1.7 | 70.8 | null | 2015-02-15 | 2015-02-15 | CARBOPLATIN + RT | null | null | 280027353 | CARBOPLATIN + RT |
| 280008379 | 280008924 | 1.65 | 101 | Palliative (P) | 2013-09-23 | 2013-11-11 | Ifosfamide | Y | N | 280027354 | IFOSFAMIDE |
| 280008380 | 280005569 | 1.68 | 91.5 | Palliative (P) | 2016-03-07 | 2016-03-08 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280027360 | PACLITAXEL |
| 280008381 | 280005569 | 0 | 94.2 | Palliative (P) | 2014-11-24 | 2015-01-05 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280027360 | RMS 2005 TRIAL |
| 280008382 | 280011329 | 1.63 | 56.5 | Palliative (P) | 2015-07-13 | 2015-07-27 | Cisplatin 7 day | 1 | N | 280027368 | CISPLATIN |
| 280008383 | 280005570 | 1.61 | 64 | Palliative (P) | null | 2013-08-16 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280027369 | PACLITAXEL |
| 280008384 | 280005571 | 1.78 | 74.8 | Curative (C) | 2015-04-02 | 2015-04-28 | Cisplatin | N | Y | 280027377 | CISPLATIN |
| 280008385 | 280008926 | 1.67 | 68.05 | Adjuvant (A) | 2015-02-12 | 2015-03-01 | Doxorubicin 75mg/m2 | Y | N | 280027379 | DOXORUBICIN |
| 280008386 | 280008927 | 1.58 | 45.1 | Neo-adjuvant (N) | 2014-05-31 | 2014-06-21 | Cetuximab + Radiotherapy Maint | N | Y | 280027379 | CETUXIMAB + RT |
| 280008389 | 280005575 | 1.74 | 78.2 | Palliative (P) | 2017-06-20 | 2017-06-26 | Paclitaxel 80mg/m2 day 1 8 15 | Y | N | 280027394 | PACLITAXEL |
| 280008390 | 280005576 | 1.54 | 62.6 | Palliative (P) | 2014-12-10 | 2014-12-10 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280027394 | IVA |
| 280008391 | 280005577 | 1.5 | null | null | 2015-11-04 | 2015-11-27 | Cisplatin | N | Y | 280027395 | CISPLATIN |
| 280008392 | 280005578 | 1.62 | 103 | Curative (C) | 2014-10-22 | 2014-10-27 | Cisplatin | N | null | 280027400 | CISPLATIN |
| 280008393 | 280005578 | 1.56 | null | Neo-adjuvant (N) | 2015-03-17 | 2015-08-26 | Ifosfamide | N | N | 280027400 | IFOSFAMIDE |
| 280008394 | 280008933 | 1.78 | 171 | Curative (C) | 2016-06-07 | 2016-06-18 | CARBOPLATIN + RT | null | null | 280027404 | CARBOPLATIN + RT |
| 280008395 | 280008933 | 1.62 | 48.1 | Palliative (P) | 2014-06-30 | 2014-06-30 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 280027404 | PACLITAXEL |
| 280008396 | 280005581 | 1.74 | 73.5 | Not known (9) | 2014-11-10 | 2014-11-10 | Paclitaxel 7 day | null | null | 280027410 | PACLITAXEL |
| 280008397 | 280005583 | 1.8 | 72.6 | Palliative (P) | null | 2016-02-01 | Ifosfamide | N | N | 280027424 | IFOSFAMIDE |
| 280008398 | 280005584 | 1.52 | null | Not known (9) | 2015-10-16 | 2016-01-11 | IVA | N | N | 280027424 | IVA |
| 280008399 | 280005586 | 1.68 | 89 | Neo-adjuvant (N) | 2014-07-03 | 2014-08-24 | Doxorubicin 75mg/m2 | 02 | N | 280027434 | DOXORUBICIN |
| 280008400 | 280008936 | 1.58 | 81 | Neo-adjuvant (N) | 2013-08-27 | 2013-09-18 | Cisplatin | N | Y | 280027435 | CISPLATIN |
| 280008401 | 280005588 | null | 80.5 | Neo-adjuvant (N) | null | 2015-09-29 | Cisplatin | null | N | 280027444 | CISPLATIN |
| 280008402 | 280005589 | null | 73.4 | Disease modification (D) | 2018-05-24 | 2018-05-24 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280027445 | RMS 2005 TRIAL |
| 280008403 | 280005590 | 1.98 | 110.2 | Palliative (P) | 2015-09-24 | 2015-09-29 | Cetuximab + Radiotherapy Maint | Y | Y | 280027445 | CETUXIMAB + RT |